The Food and Drug Administration plans to limit approval of updated COVID-19 vaccines to adults 65 and older and individuals over 6 months old with at least one high-risk health condition. That includes people with asthma, cancer, diabetes, obesity and pregnant women. The change narrows prior universal recommendations and aligns U.S. policy more closely with international approaches.
U.S.

FDA limits COVID-19 vaccine approval to seniors, high-risk groups

0:48

The FDA will restrict COVID-19 vaccine approval to high-risk groups, requiring new trials for healthy Americans under 65.


Latest News

Daily Newsletter

Start your day with fact-based news

Start your day with fact-based news

Learn more about our emails. Unsubscribe anytime.

By entering your email, you agree to the Terms and Conditions and acknowledge the Privacy Policy.